OZEKIBART
UNII R0GA5221D4

Substance Identification & Data

This profile provides standardized clinical and technical data for Ozekibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R0GA5221D4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2539847-03-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

R0GA5221D4

CAS Registry Number

2539847-03-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OZEKIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C157062

National Cancer Institute reference terminology for clinical and research data.

INN ID

12417

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-151

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ozekibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OZEKIBART

Common Names & Synonyms

IMMUNOGLOBULIN, ANTI-(HUMAN DEATH RECEPTOR 5) (HUMAN-LAMA GLAMA CLONE IF5 SINGLE-DOMAIN VHH FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (GGS)2 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN DEATH RECEPTOR 5) (HUMAN-LAMA GLAMA CLONE IF5 SINGLE-DOMAIN VHH FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (GGGG) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (DE-269-GLUTAMIC ACID,DE-270-LEUCINE,DE-271-LEUCINE) (HUMAN .GAMMA.1-CHAIN C REGION C-TERMINAL FRAGMENT), DIMER

INBRX 109 [WHO-DD]

OZEKIBART [INN]

OZEKIBART [USAN]